Drug Shortage Report for MULTIHANCE
Report ID | 246225 |
Drug Identification Number | 02248302 |
Brand name | MULTIHANCE |
Common or Proper name | Gadobenate Dimeglumine injection |
Company Name | BRACCO IMAGING CANADA |
Market Status | MARKETED |
Active Ingredient(s) | GADOBENATE DIMEGLUMINE |
Strength(s) | 529MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5ml, 10ml,15ml, 20ml, 50ml |
ATC code | V08CA |
ATC description | MAGNETIC RESONANCE IMAGING CONTRAST MEDIA |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-12-17 |
Estimated end date | 2025-02-14 |
Actual end date | 2025-02-14 |
Shortage status | Resolved |
Updated date | 2025-03-17 |
Company comments | The manufacturing and release of the product at the approved manufacturing site are suspended until issue is identified and resolved. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11065 BOUL. L-H LAFONTAINE VILLE D'ANJOU, QUEBEC CANADA H1J 2Z4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2025-03-17 | French | Compare |
v8 | 2025-03-17 | English | Compare |
v7 | 2025-03-13 | French | Compare |
v6 | 2025-03-13 | English | Compare |
v5 | 2025-01-09 | French | Compare |
v4 | 2025-01-09 | English | Compare |
v3 | 2024-12-20 | French | Compare |
v2 | 2024-12-20 | English | Compare |
v1 | 2024-12-20 | English | Compare |
Showing 1 to 9 of 9